EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype

Anastasiya A Kobelyatskaya iD, Elena A Pudova iD, Irina V Katunina, Anastasiya V Snezhkina iD, Maria S Fedorova iD, Vladislav S Pavlov iD, Anastasiya O Kotelnikova iD, Kirill M Nyushko iD, Boris Y Alekseev, George S Krasnov iD, Anna V Kudryavtseva iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anastasiya A Kobelyatskaya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular heterogeneity in prostate cancer (PCa) is one of the key reasons underlying the differing likelihoods of recurrence after surgical treatment in individual patients of the same clinical category. In this study, we performed RNA-Seq profiling of 58 localized PCa and 43 locally advanced PCa tissue samples obtained as a result of radical prostatectomy on a cohort of Russian patients. Based on bioinformatics analysis, we examined features of the transcriptome profiles within the high-risk group, including within the most commonly represented molecular subtype, TMPRSS2-ERG. The most significantly affected biological processes in the samples were also identified, so that they may be further studied in the search for new potential therapeutic targets for the categories of PCa under consideration. The highest predictive potential was found with the EEF1A1P5, RPLP0P6, ZNF483, CIBAR1, HECTD2, OGN, and CLIC4 genes. We also reviewed the main transcriptome changes in the groups at intermediate risk of PCa—Gleason Score 7 (groups 2 and 3 according to the ISUP classification)—on the basis of which the LPL, MYC, and TWIST1 genes were identified as promising additional prognostic markers, the statistical significance of which was confirmed using qPCR validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMaleHumansProstateRisk FactorsGene Expression ProfilingProstatectomyTranscriptomeOncogene Proteins, FusionTranscriptional Regulator ERGBiomarkers, TumorChloride ChannelsSerine Endopeptidases

Stichwörter der Autor:innen

ISUPRNA-SeqTMPRSS2-ERGgene expressionheterogeneitymolecular subtypepathwaysprostate cancerrisk groupstranscriptome

Substanzen

Oncogene Proteins, FusionTranscriptional Regulator ERGBiomarkers, TumorERG protein, humanCLIC4 protein, humanChloride ChannelsTMPRSS2 protein, humanSerine EndopeptidasesTMPRSS2-ERG fusion protein, human

Autor:innen und Institutionen

  • Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
  • National Medical Research Radiological Center, Ministry of Health of the Russian Federation, 125284 Moscow, Russia.

ORCID-Profile: Anastasiya A Kobelyatskaya, Elena A Pudova, Anastasiya V Snezhkina, Maria S Fedorova, Vladislav S Pavlov, Anastasiya O Kotelnikova, Kirill M Nyushko, George S Krasnov, Anna V Kudryavtseva

Förderung

  • Russian Science Foundation

Zitieren

APA

Kobelyatskaya, A. A., Pudova, E. A., Katunina, I. V., Snezhkina, A. V., Fedorova, M. S., Pavlov, V. S., Kotelnikova, A. O., Nyushko, K. M., Alekseev, B. Y., Krasnov, G. S., & Kudryavtseva, A. V. (2023). Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119282

Vancouver

Kobelyatskaya AA, Pudova EA, Katunina IV, Snezhkina AV, Fedorova MS, Pavlov VS, et al. Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119282

BibTeX
@article{Kobelyatskaya2023,
  author = {Kobelyatskaya, Anastasiya A and Pudova, Elena A and Katunina, Irina V and Snezhkina, Anastasiya V and Fedorova, Maria S and Pavlov, Vladislav S and Kotelnikova, Anastasiya O and Nyushko, Kirill M and Alekseev, Boris Y and Krasnov, George S and Kudryavtseva, Anna V},
  title = {Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119282}
}
Kostenlos starten →